Design of immune-based interventions in autoimmunity and viral infections - The need for predictive models that integrate time, dose and classes of immune responses

Novartis Foundation Symposium

Volumn 239, Issue , 2001, Pages 16-24

  Von Herrath, Matthias G ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; AUTOIMMUNITY; BIOLOGICAL MODEL; IMMUNOLOGY; PREDICTION AND FORECASTING; REVIEW; TIME; VIRUS INFECTION;

ANIMALS; AUTOIMMUNITY; MODELS, IMMUNOLOGICAL; PREDICTIVE VALUE OF TESTS; TIME FACTORS; VIRUS DISEASES;

EID: 0039146141     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (27)

1. Balasa B, Sarvetnick N 1996 The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J Autoimmun 9:283-286
2. Bot A, Holz A, Christen U et al 2000 Local IL-4 expression in the lung reduces pulmonary influenza-virus-specific secondary cytotoxic T cell responses. Virology 269:66-77
3. Christen U, Wolfe T, Hughes A, Green A, Flavell R, von Herrath MG 2001 A dual effect of TNFa in type 1 diabetes. J Immnol, in press
4. Coon B, An L-L, Whitton JL, von Herrath MG 1999 DNA immunization to prevent autoimmune diabetes. J Clin Invest 104:189-194
5. Cope AP, Ettinger R, McDevitt H 1997a The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire. Res Immunol 148:307-312
6. Cope AP, Liblau RS, Yang XD et al 1997b Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J Exp Med 185:1573-1584
7. Homann D, Holz A, Bot A et al 1999 Autoreactive CD4+ lymphocytes protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity 11:463-472
8. Horwitz MS, Krahl T, Fine C, Lee J, Sarvetnick N 1999 Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J Virol 73:1756-1766
9. Itoh M, Takahashi T, Sakaguchi N et al 1999 Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162:5317-5326
10. King C, Davies J, Mueller R et al 1998 TGF-betal alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 5:601-603
11. Klavinskis L, Whitton JL, Joly E, Oldstone MBA 1990 Vaccination and protection from a lethal viral infection: identification, incorporation, and use of a cytotoxic T lymphocyte glycoprotein epitope. Virology 178:393-400
12. Lee MS, Wogensen L, Shizuru J, Oldstone MBA, Sarvetnick N 1994 Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. J Clin Invest 93:1332-1338
13. Lee MS, von Herrath MG, Reiser H, Oldstone MBA, Sarvetnick N 1995 Sensitization to self (virus) antigen by in situ expression of interferon-γ. J Clin Invest 95:486-492
14. Liblau RS, Singer SM, McDevitt H 1995 Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38
15. Matsue H, Matsue K, Walters M, Okumura K, Yagita H, Takashima A 1999 Induction of antigen-specific immunosuppression by CD95L cDNA-transfected 'killer' dendritic cells. Nat Med 5:930-937
16. Racke MK, Bonomo A, Scott DE et al 1994 Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961-1966
17. Rocken M, Racke M, Shevach EM 1996 IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17:225-231
18. Seddon B, Mason D 1999 Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J Exp Med 189:877-882
19. von Herrath MG 1998 Selective immunotherapy of IDDM: a discussion based on new findings from the RIP-LCMV model for autoimmune diabetes. Transplant Proc 30:4115-4121
20. von Herrath MG, Oldstone MBA 1997 Interferon-gamma? is essential for beta cells and development of insulin-dependent diabetes mellitus. J Exp Med 185:531-539
21. von Herrath MG, Guerder S, Lewicki H, Flavell R, Oldstone MBA 1995a Coexpression of B7-1 and viral ('self') transgenes in pancreatic beta-cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes. Immunity 3:727-738
22. von Herrath MG, Allison J, Miller JF, Oldstone MBA 1995b Focal expression of interleukin-2 does not break unresponsiveness to 'self' (viral) antigen expressed in beta cells but enhances development of autoimmune disease (diabetes) after initiation of an anti-self immune response. J Clin Invest 95:477-485
23. von Herrath MG, Dyrberg T, Oldstone MBA 1996 Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98:1324-1331
24. von Herrath MG, Coon B, Lewicki H, Mazarguil H, Gairin JE, Oldstone MBA 1998 In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes. J Immunol 161:5087-5096
25. von Herrath MG, Coon B, Homann D, Wolfe T, Guidotti LG 1999 Thymic tolerance to only one viral protein reduces lymphocytic choriomeningitis virus-induced immunopathology and increases survival in perforin-deficient mice. J Virol 73:5918-5925
26. Weiner HL 1997 Oral tolerance for the treatment of autoimmune diseases. Annu Rev Med 48:341-351
27. Wogensen L, Huang X, Sarvetnick N 1993 Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans. J Exp Med 178:175-185